Long‐Term Effect of Metabolic Syndrome With and Without Diabetes Mellitus on Coronary Revascularization in Japanese Patients Undergoing Percutaneous Coronary Intervention

摘要

Background:Metabolic syndrome (MS) plays a crucial role in the long‐term prognosis and primary or secondary prevention of coronary artery disease, regardless of the presence or absence of diabetes mellitus (DM). We previously reported that after percutaneous coronary intervention (PCI), patients with MS had worse long‐term outcome. However, there is no evidence indicating the importance of MS with and without DM on re‐revascularization procedures in Japanese patients undergoing PCI.